Profit, payment and pharmaceutical practices: Perspectives from hospitals in Bangkok

Health Policy

Volumn 46, Issue 3, 1999, Pages 179-194

  Pitaknetinan, Kitti ^a   Tangcharoensathien, Viroj ^b   Supachutikul, Anuwat ^b   Bennett, Sara ^c   Mills, Anne ^c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Thailand Health Systems Research Institute   (Thailand)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Appropriate prescribing; Drug management; Private hospitals

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HOSPITAL MANAGEMENT; NONHUMAN; PRESCRIPTION; PUBLIC HOSPITAL; THAILAND;

DATA COLLECTION; DRUG COSTS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FORMULARIES, HOSPITAL; HEALTH POLICY; HEALTH SERVICES RESEARCH; PHARMACY SERVICE, HOSPITAL; PRIVATE SECTOR; THAILAND;

EID: 0032966272     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(98)00066-9     Document Type: Article

References (17)

1. Quick J.D., Tolentino R.B. Global comparative pharmaceutical expenditures. 1997;WHO, Geneva. DAP series.
2. Uplekar M. Implications of prescribing patterns of private doctors in the treatment of tuberculosis in Bombay, India. 1989;Takemi Program in International Health, Harvard School of Public Health, Boston.
3. Greenhalgh T. Drug prescription and self-medication in India: an exploratory survey. Social Science and Medicine. 25:1987;307-318.
4. Bennett S. The mystique of markets: public and private health care in developing countries. 1991;London School of Hygiene and Tropical Medicine, London. PHP Departmental Publication No. 4.
5. Tangcharoensathien V. Backround information. Payment mechanisms: efficiency and quality of care in the nine hospitals of Bangkok. 1:1996;HSRI, Bangkok.
6. Brugha R., Zwi A. Improving the quality of private sector delivery of public health services: challenges and strategies. Health Policy and Planning. 13(2):1998;107-120.
7. Goel P., Ross-Degnan D., Berman P., Soumerai S. Retail pharmacies in developing countries: a behavior and intervention framework. Social Science and Medicine. 42(8):1996;1155-1161.
8. Bennett S., Quick J.D., Velasquez G. Public-private roles in the pharmaceutical sector: implications for equitable access and rational drug use. Health economics and drugs. 1997;WHO, Geneva. DAP series No 5.
9. Schwartz R.K., Soumerai S.B., Avorn J. Physician motivations for non-scientific drug prescribing. Social Science and Medicine. 28(6):1989;577-582.
10. Wyatt H.V. The popularity of injections in the Third World: origins and consequences for poliomyelitis. Social Science and Medicine. 19:1984;911-915.
11. Cunningham C.E. Thai 'injection doctors' antibiotic mediators. Social Science and Medicine. 4:1970;1-24.
12. Wibulpolprasert S. Thai drug system: a situation analysis for further development. 1995;Thailand Health Research Institute, Bangkok. unpublished.
13. Tangcharoensathien V., Supachutikul A., Nittayaramphong S. Cost recovery of hospitals under the Ministry of Public Health. Chulalongkorn Medical Journal. 36(8):1992;593-599.
14. Tangcharoensathien V, Supachutikul A. Compulsory health insurance development in Thailand. Paper presented at the International Conference on 'Economics of Health Insurance in Low and Middle-Income Countries', Antwerp, Belgium, 1997.
15. Pannarunothai S., Mills A. The poor pay more: health related inequality in Thailand. Social Science and Medicine. 44(12):1997;1781-1790.
16. Managing drug supply. 1997;Kumarian Press, CT, USA.
17. Swan M., Zwi A. Private practitioners and public health: close the gap or increase the distance? 1997;Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London. PHP Publication No. 24.